Mark Wassersug - 11 Apr 2022 Form 4 Insider Report for Intercontinental Exchange, Inc. (ICE)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
12 Apr 2022, 16:33:51 UTC
Prior SEC filing
11 Mar 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Octavia N. Spencer, Attorney-in-fact

Key filing fact

Mark Wassersug filed Form 4 for Intercontinental Exchange, Inc. (ICE) on 12 Apr 2022.

Key facts

  • This page summarizes Mark Wassersug's Form 4 filing for Intercontinental Exchange, Inc. (ICE).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 12 Apr 2022, 16:33.

Change

  • Previous filing in this sequence was filed on 11 Mar 2022.
  • Current net transaction value: -$783,474.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICE transaction

Common Stock

Options Exercise

Transaction value
$630,410
Shares
+11,000
Change %
+40%
Price
$57.31
Shares after
38,229
Date
11 Apr 2022
Ownership
Direct
Footnotes
F1
ICE transaction

Common Stock

Sale

Transaction value
$1,413,884
Shares
-11,000
Change %
-29%
Price
$128.53
Shares after
27,229
Date
11 Apr 2022
Ownership
Direct
Footnotes
F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ICE transaction Derivative

Employee Stock Option (right to buy) Holding

Options Exercise

Transaction value
$0
Shares
-11,000
Change %
-78%
Price
$0.000000
Shares after
3,028
Date
11 Apr 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
11,000
Exercise price
$57.31
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended.

Footnote F2

The price range for the aggregate amount sold by the direct holder is $127.42 - $129.65. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.

Footnote F3

The common stock number referred in Table I is an aggregate number and represents 18,058 shares of common stock and 9,171 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2022 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023 and will be reported at the time of vesting. The satisfaction of the 2020, 2021 and 2022 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2023, February 2024 and February 2025, respectively, and will be reported at the time of vesting.

Footnote F4

These options are fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .